and synthesis (desmosterol), as well as CRP were quantified at baseline and end of study. Results: One hundred and twenty two individuals were included. Atorvastatin alone or combined with ezetimibe reduced both LDL-cholesterol and CRP (P<0.002 vs. baseline); ezetimibe did not modify CRP. Reduction in absorption markers was observed in ezetimibe-based therapies, whereas atorvastatin alone increased these biomarkers (P<0.03 vs. baseline). In addition, ezetimibe also increased desmosterol plasma levels (P=0.004).
Introduction: Central sleep apnea (CSA) is associated with increased morbidity and mortality and frequently occurs in heart failure patients. Current treatment options for CSA have been limited and focus on mask based therapies and therefore are highly dependent on tolerability and adherence. A novel therapy utilizing phrenic nerve stimulation was developed using the remedē System, a transvenous, fully implantable system which is intended to restore a normal breathing pattern throughout the night. This is the first study to evaluate the effects of chronic respiratory rhythm management utilizing the remedē ® System through 3 and 6 months. Methods: Subjects received a remedē ® System consisting of a respistim™ transvenous stimulation lead (in either the left pericardiophrenic vein or the right brachiocephalic vein) and a remedç ® pulse generator (IPG) which was placed in the pectoral area and secured in a normal fashion. Forty-seven subjects with predominantly CSA (mean age 66±10 years, mean baseline AHI 50±15 n/hour) were evaluated at baseline and after 3 and 6 months of therapy. Fifty-three percent of subjects had a concomitant cardiac device and 79% of subjects had chronic heart failure. Standard polysomnographic criteria were used for classification of disordered events and arousals. Background: Familial hypertrophic cardiomyopathy (HCM) is frequently caused by mutations in genes encoding sarcomeric proteins. It has been hypothesized that these mutations increase ATP utilization for sarcomere contraction and thereby increase energy demand of the heart. Previous studies in single left ventricular myofibrils from myocardium harboring the first identified causal HCM mutation R403Q in the gene (MYH7) encoding β-myosin heavy chain revealed increased kinetics suggesting a 3-fold increase in energy cost of tension generation. In the present study we investigated if sarcomere contraction is indeed less economic in human hearts harboring the heterozygous R403Q mutation or a homozygous troponin T mutation (TNNT2/K280N). Methods and results: Force generating capacity and ATP utilization were simultaneously measured at maximal and submaximal activating calcium concentrations in muliticellular muscle strips to determine economy of sarcomere contraction defined as tension cost (ATP needed for force generation). Measurements in HCM samples with MYH7 (MYH7/R403Q) and TNNT2 (TNNT2/K280N) mutations were compared with control samples from sarcomere mutation-negative patients (HCMsmn) and patients with secondary left ventricular hypertrophy due to aortic stenosis (LVHao). A significantly higher tension cost of sarcomere contraction was found in MYH7R/403Q and TNNT2/K280N compared to HCMsmn and LVHao at maximal and submaximal activation. Exchange of endogenous mutant troponin T in the TNNT2/K280N sample with recombinant wild-type troponin restored economy of muscle contraction to values found in the controls. This proves that the mutant troponin T protein increases ATP utilization to generate a certain amount of force. Conclusion: We provide direct evidence that expression of HCM-associated mutations in the heart decreases the economy of myocardial contraction at the level of the sarcomeres. Inefficient contractility may underlie cardiac dysfunction at an early stage of HCM.
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Reduction of lymphocyte G-protein coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure Background: Increased cardiac G-protein coupled receptor kinase-2 (GRK2) expression has a pivotal role at inducing heart failure (HF)-related β-adrenergic receptor (βAR) dysfunction. Importantly, abnormalities of βAR signaling in the failing heart, including GRK2 protein levels, are mirrored in circulating lymphocytes and are directly correlated with HF severity. Exercise training has been demonstrated to exert several beneficial effects on the failing heart, including normalization of cardiac βAR function and GRK2 protein levels. In the present study we evaluated whether lymphocyte GRK2 and its changes after an exercise training program can predict long-term survival in HF patients.
Methods and results:
At this aim, we prospectively studied 193 HF patients who underwent a 3-month exercise training program. Lymphocyte GRK2 protein levels, plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) and norepinephrine were measured at baseline and after training along with clinical and functional parameters (left ventricular ejection fraction, NYHA class, and peak-VO2). Cardiac-related mortality was evaluated during a mean follow up period of 37±20 months. Exercise induced a significant reduction of lymphocyte GRK2 protein levels. Importantly, exercise related changes of GRK2 (delta values) robustly predicted survival in our study population. Interestingly, the lack of any significant effect of exercise to reduce lymphocyte GRK2 protein levels identified those HF patients with the poorest outcome.
Conclusions:
Our data offer the first demonstration that changes of lymphocyte GRK2 induced by exercise can strongly predict outcome in patients with advanced HF. Purpose: Dilated Cardiomyopathy (DCM) may be induced by different etiologies, but it is known that ion-channel disruptions play an important role. The major ion channels involved in both the depolarization and repolarization of muscle cells are the ones that regulate sodium, potassium, calcium and chloride ion fluxes. The aim of the study is to evaluate the differential gene expression of cardiac chloride and potassium ion channels that represents two ways of ion-flux alterations in DCM patients, compared to normal subjects. Methods: Experimental material was taken from 42 explanted human hearts. The RNA of 31 heart samples from DCM (DCM, n=31) patients undergoing heart transplantation and control donors (CNT, n=11) was extracted to perform a microarray profiling. We also performed qRT-PCR and Western blot analysis. Results: We focused on the study of 4 ion channels related genes, since this functional category has not previously been studied. Two chloride (CLIC2, CLCN3) were down regulated (p<0.0001) and two potassium (KCNJ5, KCNJ8) were also down regulated (p<0.0001), in DCM. Validation of the results showed a high degree of consistency with microarray results. We determined whether gene expression changes resulted in alterations at the protein level. Moreover, we observed a significant inverse relationship between the expression of CLCN3 (r=-0.7, p<0.05), p<0.05 ) and left ventricular end diastolic dimension in subjects with DCM. Conclusions: In this study we show that the expression of chloride and potassium-related genes is altered in HF of dilated non-ischemic origin. Furthermore, CLCN3, KCNJ5 and KCNJ8 mRNA levels are closely related with left ventricular end-diastolic dimension in subjects with DCM. These findings could provide a new base for therapeutic oriented studies. (CSCs) . Heart function was evaluated by cardiac MRI before and 4 weeks after G-CSF treatment. In murine CVB3-induced DCM an increase of BMCs in peripheral blood and a decrease of BMCs in bone marrow was observed. We found an enhanced migration of Very Late Antigen-4 (VLA-4+) BMCs to the diseased heart overexpressing VCAM-1 and higher numbers of CSCs. Mobilization of BMCs by G-CSF boosted homing via VCAM-1/VLA-4 interaction and reduced apoptotic cardiomyocytes. Significant improvement of cardiac function was detected by MRI in G-CSF treated mice. Blocking VCAM-1 by a neutralizing antibody reduced the G-CSF dependent effects on stem cell homing and CSC proliferation. Conclusion: This is the first study showing that in virus-induced DCM VCAM-1/VLA-4 interaction is crucial for recruitment of circulating BMCs leading to a proliferation of CSCs and to beneficial antiapoptotic effects resulting in improved cardiac function after G-CSF induced mobilization.
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Differential gene expression of cardiac chloride and potassium ion channels in human dilated non-ischemic cardiomyopathy
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